• In July 2024, KD Pharma Group acquired dsm‑firmenich’s Marine Lipids omega‑3 business, including production facilities in Piura and Mulgrave, enhancing its pharmaceutical and nutraceutical lipid manufacturing and boosting marine‑oil capacity.

• In April 2023, France-based Cerea Partners acquired Polaris, accelerating expansion into microalgae‑derived omega‑3 oils and strengthening presence in North American and Asian infant‑nutrition markets.

In this report, the Omega-3 Market has been segmented by Type, Form Type, Source, Dietary Supplements, and Geography.

Omega-3 Market, Segmentation by Type

The Omega-3 Market has been segmented by Type into Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid (EPA), and Alpha-Linolenic Acid (ALA).

Docosahexaenoic Acid (DHA)

The Docosahexaenoic Acid (DHA) segment holds a dominant share in the Omega-3 market, accounting for over 40% of the total demand. Widely known for supporting brain development, cognitive health, and vision function, DHA is prominently used in infant formula, nutraceuticals, and functional foods. Its high bioavailability and increasing consumer awareness are driving its consumption globally.

Eicosapentaenoic Acid (EPA)

Eicosapentaenoic Acid (EPA) represents approximately 35% of the Omega-3 market, primarily used for cardiovascular health and anti-inflammatory benefits. It is commonly found in dietary supplements targeting heart disease, arthritis, and mental health. The growing preference for marine-based omega-3 supplements is further accelerating EPA adoption in the health and wellness sector.

Alpha-Linolenic Acid (ALA)

Alpha-Linolenic Acid (ALA) makes up nearly 25% of the overall Omega-3 market, favored for its plant-based origin and appeal among vegan consumers. Derived mainly from sources like flaxseed, chia seeds, and walnuts, ALA is increasingly incorporated into functional foods and dietary products. Its growth is propelled by the demand for sustainable and plant-derived nutrition.

Omega-3 Market, Segmentation by Form Type

The Omega-3 Market has been segmented by Form Type into Soft Gels/Capsules, Oil, Powder, and Gummies.

Soft Gels/Capsules

Soft Gels and Capsules dominate the Omega-3 market by form, accounting for over 45% of total product consumption. Known for their convenient dosage, long shelf life, and easy portability, they are the preferred choice for dietary supplement users. This form is widely used in clinical nutrition and over-the-counter wellness products.

Oil

The Oil segment holds approximately 30% share in the Omega-3 market. It is extensively used in functional foods, infant formula, and therapeutic applications. Omega-3 oil is favored for its high concentration and ease of blending into various liquid formulations, offering versatility in both commercial and retail sectors.

Powder

Powder-based Omega-3 products contribute nearly 15% of the market and are gaining traction for their use in nutraceutical blends and sports nutrition. This form ensures stability and ease of incorporation into dry mixes, protein shakes, and meal replacements. It appeals to health-conscious consumers seeking on-the-go nutrition.

Gummies

Gummies hold a growing share of around 10% in the Omega-3 market, particularly popular among children and adults with pill fatigue. They offer a palatable format with flavored delivery, driving demand in the functional confectionery space. The segment benefits from the increasing focus on personalized nutrition and convenience.

Omega-3 Market, Segmentation by Source

The Omega-3 Market has been segmented by Source into Marine Source and Plant Source.

Marine Source

Marine-based Omega-3 accounts for nearly 70% of the total market, driven by its high content of DHA and EPA. Extracted primarily from fish oil, krill oil, and algal oil, this source is widely used in clinical nutrition and cardiovascular supplements. Its proven bioavailability and efficacy contribute to its dominant share in both pharmaceutical and nutraceutical sectors.

Plant Source

Plant-derived Omega-3 holds a share of around 30%, primarily composed of Alpha-Linolenic Acid (ALA). Sourced from flaxseed, chia seeds, hemp, and walnuts, it caters to the rising demand for vegan and sustainable alternatives. Its growth is supported by increasing awareness of plant-based nutrition and the shift toward clean-label products.

Omega-3 Market, Segmentation by Dietary Supplements

The Omega-3 Market has been segmented by Dietary Supplements into Pharmaceuticals, Infant Formulas, Food & Beverages, and Pet Food & Fish Feed

Pharmaceuticals

The Pharmaceuticals segment comprises over 40% of the Omega-3 market under dietary supplements. It is primarily used for managing cardiovascular disorders, inflammatory conditions, and neurological health. The segment benefits from strong clinical evidence supporting Omega-3’s therapeutic potential and widespread use in prescription-grade supplements.

Infant Formulas

Infant Formulas account for approximately 25% of the dietary supplements market for Omega-3. DHA-enriched formulas are increasingly recommended to support brain and visual development in infants. Growing parental awareness and evolving pediatric guidelines are boosting the adoption of Omega-3 in early-life nutrition products.

Food & Beverages

Omega-3 fortified Food & Beverages contribute around 20% to the segment, with applications in dairy products, bakery items, and functional drinks. This segment appeals to health-conscious consumers seeking preventive nutrition through everyday diets. Demand is driven by trends in functional foods and clean-label innovation.

Pet Food & Fish Feed

Pet Food and Fish Feed represent nearly 15% of the Omega-3 dietary supplements market. Omega-3 is added to enhance joint health, skin condition, and cognitive function in pets, as well as to improve the growth performance and disease resistance in aquaculture. The rising emphasis on animal wellness is expanding its application in this segment.

Omega-3 Market, Segmentation by Geography

In this report, the Omega-3 Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Omega-3 Market Share (%), by Geographical Region

North America

North America holds a leading position in the Omega-3 market with over 35% share, driven by high consumer awareness and a robust nutraceutical industry. The region benefits from the growing use of Omega-3 in clinical nutrition, dietary supplements, and functional foods. Strong healthcare infrastructure and supportive regulatory frameworks further contribute to market expansion.

Europe

Europe accounts for around 25% of the Omega-3 market. The increasing preference for plant-based and sustainable sources, especially in countries like Germany, France, and the UK, is reshaping market dynamics. The region also emphasizes clean-label formulations and has a mature consumer base for health and wellness products.

Asia Pacific

The Asia Pacific region captures close to 20% share and is experiencing rapid growth due to rising awareness of preventive healthcare and growing consumption of infant formulas. Countries like China, Japan, and India are emerging as key markets, supported by evolving dietary habits and increased demand for fortified food products.

Middle East and Africa

Middle East and Africa contribute approximately 10% to the Omega-3 market. The region is witnessing increased incorporation of Omega-3 in pharmaceuticals and nutritional products, especially in urban centers. Although market penetration is still developing, the demand is supported by growing lifestyle-related disorders and rising health awareness.

Latin America

Latin America holds about 10% of the global market share. The demand for Omega-3 is driven by rising interest in functional foods and dietary supplements, particularly in Brazil and Mexico. Government initiatives promoting healthier eating habits and the expansion of the retail nutrition sector are boosting market growth in the region.

This report provides an in depth analysis of various factors that impact the dynamics of Omega-3 Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Drivers

• Rising health awareness among global consumers
• Expansion in dietary supplement consumption
• Clinical research supporting cardiovascular benefits

• Increasing demand for infant nutrition products - As pediatric health becomes a top priority for parents and healthcare providers, nutrient-rich formulations containing DHA and EPA are gaining rapid traction. These fatty acids are critical in neural development, visual acuity, and cognitive function in early life stages.

  Regulatory bodies in many countries have acknowledged the role of omega-3 in infant brain development, prompting manufacturers to develop fortified baby food, infant formulas, and prenatal supplements. This trend is reinforced by rising birth rates in developing nations and increased spending on premium infant nutrition.

  With growing clinical evidence supporting omega-3’s benefits in reducing the risk of developmental disorders, companies are investing in advanced formulations. This includes microencapsulation and algal oil-based DHA to address stability and dietary concerns. Label transparency and clean ingredient sourcing further boost product appeal among informed consumers.

  This momentum offers omega-3 manufacturers strong entry points into pediatric healthcare, pharmaceutical-grade supplements, and premium nutrition markets, ultimately expanding their global reach.

Restraints

• High extraction and purification costs
• Limited availability of marine sources
• Unpleasant taste and odor issues

• Regulatory barriers in certain regions - The omega-3 market faces considerable hurdles due to regulatory disparities and compliance complexities across regions. In many countries, the classification of omega-3 products as supplements, drugs, or functional foods leads to varied approval requirements, labeling restrictions, and claims limitations, affecting market entry and product positioning.

  Companies often encounter delays in product launches due to the need for clinical validation, toxicological assessments, and regulatory approvals. These factors raise the overall cost of product development and commercialization. Emerging markets with stringent food safety norms and import restrictions also pose operational challenges for global manufacturers.

  Marketing claims related to health benefits of omega-3s—such as heart health or cognitive function—are closely scrutinized by regulatory agencies like the FDA, EFSA, and others. This limits companies’ ability to differentiate products and build consumer trust through scientific messaging.

  To remain competitive, businesses must navigate this regulatory landscape with regional expertise, legal support, and product reformulation strategies, which adds complexity to global expansion efforts.

Opportunities

• Innovation in plant-based omega-3 sources
• Fortification of functional food and beverages
• Growing vegan and flexitarian consumer base

• Advancements in microencapsulation delivery technologies - Recent advancements in microencapsulation technology are opening up new avenues for omega-3 product innovation. These technologies enable the encapsulation of sensitive oils like DHA and EPA in protective coatings, which preserve their nutritional integrity, stability, and bioavailability across food and supplement applications.

  Microencapsulation helps mask the unpleasant odor and taste commonly associated with omega-3s, improving consumer acceptance and product versatility. This allows omega-3s to be included in a wider range of food products—including cereals, bakery items, beverages, and dairy—without compromising flavor or shelf life.

  Advanced encapsulation techniques, such as spray-drying, coacervation, and liposomal delivery systems, also enhance omega-3 absorption in the body. These innovations support the development of targeted, high-performance nutraceuticals for specific health concerns such as cardiovascular wellness, brain function, and inflammation control.

  As functional food and personalized nutrition continue to rise, microencapsulated omega-3s present a competitive advantage by enabling formulation flexibility, extended product shelf life, and improved user compliance in global markets.

Key players in Omega-3 Market include:

• BASF SE
• Cargill, Incorporated
• DSM‑Firmenich
• Archer Daniels Midland (ADM)
• Kerry Group
• Croda International
• Orkla
• Corbion
• Aker BioMarine
• Polaris
• Omega Protein Corporation
• Lonza Group
• Glanbia

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Market Share Analysis
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis